Plasma phosphate and all-cause mortality in individuals with and without type 2 diabetes: the Dutch population-based lifelines cohort study

被引:6
作者
van der Vaart, Amarens [1 ,2 ]
Cai, Qingqing [1 ,3 ]
Nolte, Ilja M. [4 ]
van Beek, Andre P. J. [2 ]
Navis, Gerjan [1 ]
Bakker, Stephan J. L. [1 ]
van Dijk, Peter R. [2 ]
de Borst, Martin H. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Med, POB 30-001, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Div Endocrinol, Dept Med, POB 30-001, NL-9700 RB Groningen, Netherlands
[3] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Natl Clin Res Ctr Kidney Dis,Div Nephrol, Guangzhou, Peoples R China
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
关键词
Phosphate; Type; 2; diabetes; All-cause mortality; SERUM PHOSPHORUS; CALCIFICATION; PREVALENCE; MORBIDITY; CALCIUM; BURDEN;
D O I
10.1186/s12933-022-01499-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Individuals with type 2 diabetes have a substantially elevated cardiovascular risk. A higher plasma phosphate level promotes vascular calcification, which may adversely affect outcomes in individuals with type 2 diabetes. We hypothesized that the association between plasma phosphate and all-cause mortality is stronger in individuals with type 2 diabetes, compared to those without diabetes. Methods We analysed the association between plasma phosphate and all-cause mortality in the Dutch population-based Lifelines cohort and in subgroups with and without type 2 diabetes, using multivariable Cox regression adjusted for potential confounders. Effect modification was tested using multiplicative interaction terms. Results We included 57,170 individuals with 9.4 [8.8-10.4] years follow-up. Individuals within the highest phosphate tertile (range 1.00-1.83 mmol/L) were at higher risk of all-cause mortality (fully adjusted HR 1.18 [95% CI 1.02-1.36], p = 0.02), compared with the intermediate tertile (range 0.85-0.99 mmol/L). We found significant effect modification by baseline type 2 diabetes status (p-interaction = 0.003). Within the type 2 diabetes subgroup (N = 1790), individuals within the highest plasma phosphate tertile had an increased mortality risk (HR 1.73 [95% CI 1.10-2.72], p = 0.02 vs intermediate tertile). In individuals without diabetes at baseline (N = 55,380), phosphate was not associated with mortality (HR 1.12 [95% CI 0.96-1.31], p = 0.14). Results were similar after excluding individuals with eGFR < 60 mL/min/1.73 m(2). Discussion High-normal plasma phosphate levels were associated with all-cause mortality in individuals with type 2 diabetes. The association was weaker and non-significant in those without diabetes. Measurement of phosphate levels should be considered in type 2 diabetes; whether lowering phosphate levels can improve health outcomes in diabetes requires further study.
引用
收藏
页数:10
相关论文
共 33 条
[1]   Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α [J].
Aghagolzadeh, Parisa ;
Bachtler, Matthias ;
Bijarnia, Rakesh ;
Jackson, Christopher ;
Smith, Edward R. ;
Odermatt, Alex ;
Radpour, Ramin ;
Pasch, Andreas .
ATHEROSCLEROSIS, 2016, 251 :404-414
[2]   Serum phosphorus, cardiovascular and all-cause mortality in the general population: A meta-analysis [J].
Bai, Wenwei ;
Li, Jing ;
Liu, Juan .
CLINICA CHIMICA ACTA, 2016, 461 :76-82
[3]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[4]   Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].
Bierhaus, A ;
Schiekofer, S ;
Schwaninger, M ;
Andrassy, M ;
Humpert, PM ;
Chen, J ;
Hong, M ;
Luther, T ;
Henle, T ;
Klöting, I ;
Morcos, M ;
Hofmann, M ;
Tritschler, H ;
Weigle, B ;
Kasper, M ;
Smith, M ;
Perry, G ;
Schmidt, AM ;
Stern, DM ;
Häring, HU ;
Schleicher, E ;
Nawroth, PP .
DIABETES, 2001, 50 (12) :2792-2808
[5]   Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes [J].
Chonchol, Michel ;
Dale, Rita ;
Schrier, Robert W. ;
Estacio, Raymond .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04) :380-386
[6]   Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population The PREVEND Study [J].
Eelderink, Coby ;
te Velde-Keyzer, Charlotte A. ;
Frenay, Anne-Roos S. ;
Vermeulen, Emma A. ;
Bachtler, Matthias ;
Aghagolzadeh, Parisa ;
van Dijk, Peter R. ;
Gansevoort, Ronald T. ;
Vervloet, Marc G. ;
Hillebrands, Jan-Luuk ;
Bakker, Stephan J. L. ;
van Goor, Harry ;
Pasch, Andreas ;
de Borst, Martin H. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (08) :1942-1951
[7]   Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 [J].
Einarson, Thomas R. ;
Acs, Annabel ;
Ludwig, Craig ;
Panton, Ulrik H. .
CARDIOVASCULAR DIABETOLOGY, 2018, 17
[8]   U-shaped relationship between serum phosphate and cardiovascular risk: A retrospective cohort study [J].
Hayward, Nicholas ;
McGovern, Andrew ;
de Lusignan, Simon ;
Cole, Nicholas ;
Hinton, William ;
Jones, Simon .
PLOS ONE, 2017, 12 (11)
[9]   The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease [J].
Hoff, JA ;
Quinn, L ;
Sevrukov, A ;
Lipton, RB ;
Daviglus, M ;
Garside, DB ;
Ajmere, NK ;
Gandhi, S ;
Kondos, GT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :1008-1012
[10]   Bone morphogenetic protein 2: A potential new player in the pathogenesis of diabetic retinopathy [J].
Hussein, Khaled A. ;
Choksi, Karishma ;
Akeel, Sara ;
Ahmad, Saif ;
Megyerdi, Sylvia ;
El-Sherbiny, Mohamed ;
Nawaz, Mohamed ;
Abu El-Asrar, Ahmed ;
Al-Shabrawey, Mohamed .
EXPERIMENTAL EYE RESEARCH, 2014, 125 :79-88